Overview

  • Product nameAnti-SLC16A9 antibody
    See all SLC16A9 primary antibodies
  • Description
    Rabbit polyclonal to SLC16A9
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Hamster, Human
  • Immunogen

    Synthetic peptide conjugated to KLH, corresponding to a region within internal sequence amino acids 201-231 of Human SLC16A9 (NP_919274.1).

  • Positive control
    • CHO cell line lysate

Properties

Applications

Our Abpromise guarantee covers the use of ab107761 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/100 - 1/500. Predicted molecular weight: 56 kDa.

Target

  • FunctionProton-linked monocarboxylate transporter. Catalyzes the rapid transport across the plasma membrane of many monocarboxylates.
  • Sequence similaritiesBelongs to the major facilitator superfamily. Monocarboxylate porter (TC 2.A.1.13) family.
  • Cellular localizationCell membrane.
  • Information by UniProt
  • Database links
  • Alternative names
    • C10orf36 antibody
    • FLJ43803 antibody
    • MCT 9 antibody
    • MCT9 antibody
    • Monocarboxylate transporter 9 antibody
    • Monocarboxylic acid transporter 9 antibody
    • MOT9_HUMAN antibody
    • SLC16A9 antibody
    • Solute carrier family 16 (monocarboxylic acid transporters) member 9 antibody
    • Solute carrier family 16 member 9 antibody
    see all

Anti-SLC16A9 antibody images

  • Anti-SLC16A9 antibody (ab107761) at 1/100 dilution + CHO cell line lysate at 35 µg

    Predicted band size : 56 kDa

References for Anti-SLC16A9 antibody (ab107761)

ab107761 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab107761.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"